COMP <GO>
ABEO vs AMRN // GROSS PROFIT MARGIN
Abeona Therapeutics Inc. (NASDAQ) VS. Amarin Corporation plc (NASDAQ) • 15-METRIC TALLY: ABEO 1
— AMRN 6
▲ GROSS PROFIT MARGIN LEADER: ABEO
LAST: $4.56 (+0.22%) • MKT CAP: $260.8M
gross-margins
73.70%
LAST: $12.74 (-0.08%) • MKT CAP: $262.8M
gross-margins
56.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ABEO VS. AMRN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ABEO | AMRN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 73.70% | 56.60% | +17.10 | ABEO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -12.20% | -22.80 | AMRN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 2.56% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -23.50% | -36.50 | AMRN | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -18.20% | -41.80 | AMRN | /net-margins <GO> |
| Revenue Growth (YoY) | — | -6.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 6/9 | -3.00 | AMRN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.1 | 46.6 | -10.58 | AMRN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $260.8M | $262.8M | -$2.0M | AMRN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ABEO REV | AMRN REV | ABEO GROSS % | AMRN GROSS % | ABEO FCF | AMRN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.8M | $213.6M | 73.7% | 56.6% | -$84.3M | $6.7M |
| FY 2024 | $0 | $228.6M | — | 35.6% | -$58.5M | -$31.0M |
| FY 2023 | $3.5M | $306.9M | — | — | -$37.0M | $6.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ABEO // BETA —
AMRN // BETA —